Antibacterial Compounds

HETEROCYCLIC COMPOUNDS AS E3 LIGASE INHIBITORS

COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS

Compounds and methods for inhibiting fascin

TYK2 inhibitors and compositions and methods thereof

Polo like kinase 4 inhibitors

Solid state forms of Belumosudil and Belumosudil salts

METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS

Method of synthesizing thyroid hormone analogs and polymorphs thereof

HETEROAROMATIC COMPOUNDS

ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES

BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS

KIT KINASE INHIBITORS AND METHODS OF USE THEREOF

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT

4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3

FGFR KINASE INHIBITOR AND USE THEREOF

Anti-viral compounds

COVALENT IMMUNE RECRUITER COMPOUNDS FOR IMMUNE CELL RECOGNITION AND ASSOCIATED USES

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

ACRYLAMIDE COMPOUNDS

N-ACRYLOYLINDOLES AND METHODS OF USE

Heteroaryl carboxamide compound

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

MASP-2 INHIBITORS AND METHODS OF USE

DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES

Heterocycle RMB39 Modulators

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF

HETEROARYL DIAMIDE IRE1/XBP1s ACTIVATORS

Spiroheptanyl hydantoins as ROCK inhibitors

DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof

Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof

CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY

DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

2-Methyl-Quinazolines

TEAD INHIBITORS AND USES THEREOF

SULFONAMIDE DERIVATIVES FOR PROTEIN DEGRADATION

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

SOLID FORMS OF A CDK2 INHIBITOR

SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS

PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS

HERBICIDAL TETRAZOLE COMPOUNDS

Inhibitors of NLRP3 inflammasome

COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER

THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Synthesis Method for Aminopyrimidine FAK Inhibitor Compound

SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR

INHIBITORS OF NLRP3 INFLAMMASOME

Linkers for antibody drug conjugates

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

HMOX1 inducers

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

INHIBITORS OF NLRP3 INFLAMMASOME

COMPOUNDS FOR THE TREATMENT OF SARS

CRYSTAL FORM OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND PREPARATION METHOD THEREFOR

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

HETEROARYL CARBOXAMIDE COMPOUND

NOVEL SPIROFLUORENE COMPOUND AND ORGANIC LIGHTEMITTING DEVICE INCLUDING SAME

PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS

KRAS G12D INHIBITORS

MAP KINASE KINASE (MKK7) INHIBITORS AND USES THEREOF

HERBICIDAL COMPOUNDS

SALT INDUCIBLE KINASE INHIBITORS

HEPATITIS B CORE PROTEIN MODULATORS

PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES

Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

A COMPOUND AS A THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF

SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES

INHIBITORS OF NO PRODUCTION

Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine

ANTI-VIRAL COMPOUNDS

CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS

BIOTIN DERIVATIVES

PYRIMIDINYL SULFONAMIDES AS INHIBITORS OF ACK1/TNK2 TYROSINE KINASE

PYRIMIDINONE COMPOUNDS AND USES THEREOF

PHTHALAZINE DERIVATIVES AS P2X3 INHIBITORS

NOVEL TREATMENTS OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER

STING ANTAGONISTS AND USES THEREOF

COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY

QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER

PROTEIN AND LIPID THERAPEUTIC TARGETS

THERAPEUTIC COMPOUNDS AND METHODS

COMPOUND OR SALT THEREOF, AND ANTIBODY OBTAINED BY USING THE SAME

THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE

CARM1 INHIBITORS AND USES THEREOF

TRPML MODULATORS

COMPOUNDS AND METHODS FOR TREATING A CYTOKINE-MEDIATED DISEASE

INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)

Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

CRYSTAL FORM OF RESMETIROM, PREPARATION METHOD THEREFOR, AND USE THEREOF

(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Potassium channel inhibitors

MUTANT SELECTIVE EGFR INHIBITORS AND METHODS OF USE THEREOF

SILICON COMPOUND AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME

NOVEL CAPSID ASSEMBLY INHIBITOR

CRYSTAL FORMS OF 5-FLUORO-1-(4-FLUORO-3-(4-(PYRIMIDIN-2-YL)PIPERAZINE-1-CARBONYL)BENZYL)QUINAZOLINE-2,4(1H,3H)-DIONE AND PREPARATION THEREOF

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

NEW COMPOUND

Solid state forms of Belumosudil and Belumosudil salts

CRYSTALLINE FORM OF SELINEXOR

THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF

SUBSTITUTED 1,2,4-TRIAZOLES AS INTERMEDIATES IN THE SYNTHESIS OF TYK2 INHIBITORS

INHIBITORS OF THE BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR (BPTF) AS ANTI-CANCER AGENTS

PYRROLE COMPOUNDS

HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS

Compounds for the treatment of kinase-dependent disorders

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

AMINOIMIDAZOLE FPR2 AGONISTS

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS

2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH

BENZO[H]QUINAZOLIN-4-AMINE AND THIENO[3,2-H]QUINAZOLIN-4-AMINE DERIVATIVES FOR THE TREATMENT OF CANCER

INHIBITORS OF NLRP3 INFLAMMASOME

ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

N-FORMAMIDOPYRAZOLINE DERIVATIVE AS P2X3 RECEPTOR ANTAGONIST AND USE THEREOF

MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS

PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

RAF KINASE INHIBITORS AND METHODS OF USE THEREOF

COMPOUNDS, COMPOSITIONS AND METHODS

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

3-(PYRIDAZIN-4-YL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE DERIVATIVES AS FUNGICIDES FOR CROP PROTECTION

Heteroaryl inhibitors of PDE4

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS FOR TREATING TUBERCULOSIS

Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof

NAMPT MODULATORS

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF

Bicyclic-fused heteroaryl or aryl compounds

PYRIDAZINONE COMPOUNDS

RAS INHIBITORS AND METHODS OF USING THE SAME

REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS

Quinazoline compounds and the use thereof in the treatment of cancer

QUINAZOLINE-DERIVED HCK INHIBITORS FOR USE IN THE TREATMENT OF MYD88 MUTATED DISEASES

AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

Fused Imidazole Derivatives as AHR Antagonists

ORGANIC LIGHT EMITTING ELEMENT

Prodrug of pyrrolidone derivatives as glucokinase activator

Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol

RIP1 Inhibitory Compounds and Methods for Making and Using the Same

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES

Protease inhibitors as antivirals

DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME

C-carbonothioate-substituted tryptamine derivatives and methods of using

Ring-modified proline short peptide compound and use thereof

Capsid inhibitors for the treatment of HIV

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

Pyrimidine small-molecule compound and application thereof

2-OXO-IMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS

CYANOTRIAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

AZIRIDINYL FUNCTIONAL COMPOUND

Amino Pyrimidine Derivatives

SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF

NOVEL COMPOUNDS

EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF

CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

Inhibtors of Raf kinases

LMO2 PROTEIN INHIBITORS

2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

5-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME

Compounds as nuclear transport modulators and uses thereof

ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF

HETEROARYL AND HETEROCYCLYL COMPOUNDS

INHIBITORS OF ACK1/TNK2 TYROSINE KINASE

PYRROLIDINE DERIVATIVES AND METHODS OF USE

INHIBITORS OF ACK1/TNK2 TYROSINE KINASE

AGONISTS OF ROR GAMMAt

ErbB/BTK inhibitors

HERBICIDAL COMPOUNDS

HALOALKYLPYRIDYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR

NEW PqsR INVERSE AGONISTS

PHENYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR

QUINAZOLINONE HSD17B13 INHIBITORS AND USES THEREOF

INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF

Carm1 inhibitors and uses thereof

HETEROCYCLYL PYRIMIDINES AND TRIAZINES AS NOVEL FUNGICIDES

THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF

Antimicrobial Compounds and Methods

TRICYCLIC HETEROCYCLES

Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF

Imidazole-containing inhibitors of ALK2 kinase

DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS

PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

Inhibitors of APOL1 and methods of using same

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

EFGR INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

INHIBITION OF OLIG2 ACTIVITY

ALKYNE QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

RET kinase inhibitors

NOVEL THYROID HORMONE BETA RECEPTOR AGONIST

NOVEL HETEROCYCLIC COMPOUNDS

RAF kinase inhibitors and methods of use thereof

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

Diamine derivatives as inhibitors of leukotriene Ahydrolase

MAP4K3 SMALL MOLECULE DRUG INHIBITORS AND METHODS OF USE THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME

METHIONINE METABOLIC PATHWAY INHIBITORS

SMALL MOLECULE MODULATORS OF IL-17

Substituted Heterocyclyl Derivatives as CDK Inhibitors

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

REVERSIBLE LINKERS AND USE THEREOF

QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

Heterocyclic compound

Compound, tautomer of compound or salt of compound or tautomer, method for producing same, coloring composition, dyeing method, and dyed article

ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

Polymorphs of selinexor

Polymorphs of Selinexor

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-D3) pyridazine-3-carboxamide

INDAZOLE-FUSED CYCLIC COMPOUND

TREX1 INHIBITORS AND USES THEREOF

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Modulators of cystic fibrosis transmembrane conductance regulator

COMPOUND, CMP SLURRY COMPOSITION INCLUDING THE SAME AND POLISHING METHOD USING THE SAME

PYRIMIDINE COMPOUND AS AXL INHIBITOR

BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS

SPAK/OSR INHIBITORS AND METHODS OF USING SAME

Compounds, compositions, and methods

SMALL MOLECULE MODULATORS OF IL-17

SULPHONAMIDE COMPOUNDS

AMIDO COMPOUNDS

IL-17A MODULATORS

NOVEL AMINOPYRIMIDINE EGFR INHIBITOR

HERBICIDAL COMPOUNDS

Pyrazole MAGL inhibitors

Cannabinoid receptor mediating compounds

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE

BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF

Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof

PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS

Lactams as CBL-B inhibitors selective over C-CBL

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

ALKENYL PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

PRMT5 INHIBITOR COMPOUNDS

Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 Inhibitors

SARS-COV-2 MAIN PROTEASE INHIBITORS

DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES

MAP KINASE KINASE (MKK7) INHIBITORS AND USES THEREOF

COMPOUNDS WITH TUBULIN POLYMERISATION INHIBITORY ACTIVITY AND IMMUNOMODULATORY PROPERTIES

6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME

COMPOUNDS

Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD

CANNABINOID RECEPTOR MEDIATING COMPOUNDS

Methods for Treating Huntington’s Disease

WATERBORNE CROSSLINKER COMPOSITION

FUSED RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

CYP11A1 INHIBITORS

Compounds

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

Receptor-Interacting Protein 1 Inhibitors Including Piperazine Heterocyclic Amide Ureas

1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE

Protease Inhibitors for Treatment or Prevention of Coronavirus Disease

N-(HETEROCYCLYL AND HETEROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE DERIVATIVES AS SSTR4 AGONISTS

INDOLE CARBOXAMIDE COMPOUNDS

MICROBIOCIDAL DERIVATIVES

NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF

AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS

Organic compound and electronic device and electronic apparatus thereof

CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

Inhibitors of LRRK2 kinase

PYRIDIZIN-3(2H)-ONE DERIVATIVES

Notch Inhibitors and Uses Thereof

INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT

3-(Carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

SUBSTITUTED ISOPHTHALIC ACID DIAMIDES AND THEIR USE AS HERBICIDES

TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

KRAS G12D PROTEIN INHIBITORS

METHOD FOR THE PREPARATION OF ANDROGEN RECEPTOR ANTAGONISTS AND INTERMEDIATES THEREOF

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS

LIPOXYGENASE INHIBITORS

SUBSTITUTED N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE OR N-(METHYL-D3)-NICOTINAMIDE COMPOUNDS AS IL-12, IL-23 AND/OR IFNALPHA MODULATORS

Substituted pyridazinone compound and use thereof

SOLID STATE FORMS OF APROCITENTAN AND PROCESS FOR PREPARATION THEREOF

PRODRUGS IN THE MODULATION OF INTERLEUKIN

ARYL OR HETEROARYL DERIVATIVE